You searched for lung cancer | Page 11 of 166

CRISPR-Based TB Test Detects Infection From Tongue Swabs

Posted by CLP Edit Staff | Sep 17, 2025 | Tuberculosis |

The test showed 74% detection rate in tongue swabs compared to 56% with traditional testing methods that rely on difficult-to-collect sputum samples.

Posted by CLP Edit Staff | Sep 12, 2025 | Lung Cancer |

Study of 177 patients with limited-stage small cell lung cancer demonstrates ctDNA’s potential to personalize consolidation immunotherapy decisions.

VENTANA HER2 (4B5) test is now CE-IVDR approved to identify HER2-ultralow breast cancer and HER2-positive biliary tract cancer patients.

Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.

The funding will support commercialization of the company’s extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.